Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 21

1.

Atomoxetine Induced Hypomania in a Patient with Bipolar Disorder and Adult Attention Deficit Hyperactivity Disorder.

Kumar V, Varambally S.

Indian J Psychol Med. 2017 Jan-Feb;39(1):89-91. doi: 10.4103/0253-7176.198954.

2.

Managing the comorbidity of schizophrenia and ADHD.

Gough A, Morrison J.

J Psychiatry Neurosci. 2016 Aug;41(5):E79-80. No abstract available.

3.

Manic Symptoms Due to Methylphenidate Use in an Adolescent with Traumatic Brain Injury.

Ekinci O, Direk MÇ, Ekinci N, Okuyaz C.

Clin Psychopharmacol Neurosci. 2016 Aug 31;14(3):314-7. doi: 10.9758/cpn.2016.14.3.314.

4.

Prescription stimulant use is associated with earlier onset of psychosis.

Moran LV, Masters GA, Pingali S, Cohen BM, Liebson E, Rajarethinam RP, Ongur D.

J Psychiatr Res. 2015 Dec;71:41-7. doi: 10.1016/j.jpsychires.2015.09.012. Epub 2015 Sep 21.

5.

Prescription Stimulant Use and Hospitalization for Psychosis or Mania: A Population-Based Study.

Cressman AM, Macdonald EM, Huang A, Gomes T, Paterson MJ, Kurdyak PA, Mamdani MM, Juurlink DN; Canadian Drug Safety and Effectiveness Research Network.

J Clin Psychopharmacol. 2015 Dec;35(6):667-71. doi: 10.1097/JCP.0000000000000406.

6.

Pediatric drug safety signal detection: a new drug-event reference set for performance testing of data-mining methods and systems.

Osokogu OU, Fregonese F, Ferrajolo C, Verhamme K, de Bie S, 't Jong G, Catapano M, Weibel D, Kaguelidou F, Bramer WM, Hsia Y, Wong IC, Gazarian M, Bonhoeffer J, Sturkenboom M.

Drug Saf. 2015 Feb;38(2):207-17. doi: 10.1007/s40264-015-0265-0.

7.

Acute psychosis with attention-deficit/hyperactivity disorder and oppositional-defiant disorder comorbidities.

Ding J, Gadit AM.

BMJ Case Rep. 2014 Jun 4;2014. pii: bcr2013202835. doi: 10.1136/bcr-2013-202835.

8.

Synergistic interaction between caloric restriction and amphetamine in food-unrelated approach behavior of rats.

Keller KL, Vollrath-Smith FR, Jafari M, Ikemoto S.

Psychopharmacology (Berl). 2014 Mar;231(5):825-40. doi: 10.1007/s00213-013-3300-9. Epub 2013 Oct 8.

9.

Neural activity to intense positive versus negative stimuli can help differentiate bipolar disorder from unipolar major depressive disorder in depressed adolescents: a pilot fMRI study.

Diler RS, de Almeida JR, Ladouceur C, Birmaher B, Axelson D, Phillips M.

Psychiatry Res. 2013 Dec 30;214(3):277-84. doi: 10.1016/j.pscychresns.2013.06.013. Epub 2013 Sep 27.

10.

Pharmacological treatment of attention deficit hyperactivity disorder in children and adolescents: clinical strategies.

Shier AC, Reichenbacher T, Ghuman HS, Ghuman JK.

J Cent Nerv Syst Dis. 2012 Dec 20;5:1-17. doi: 10.4137/JCNSD.S6691. Print 2013.

11.

Methylphenidate in mania project (MEMAP): study protocol of an international randomised double-blind placebo-controlled study on the initial treatment of acute mania with methylphenidate.

Kluge M, Hegerl U, Sander C, Dietzel J, Mergl R, Bitter I, Demyttenaere K, Gusmão R, Gonzalez-Pinto A, Perez-Sola V, Vieta E, Juckel G, Zimmermann US, Bauer M, Sienaert P, Quintão S, Edel MA, Bolyos C, Ayuso-Mateos JL, López-García P.

BMC Psychiatry. 2013 Feb 27;13:71. doi: 10.1186/1471-244X-13-71.

12.

Amphetamine-induced psychosis--a separate diagnostic entity or primary psychosis triggered in the vulnerable?

Bramness JG, Gundersen ØH, Guterstam J, Rognli EB, Konstenius M, Løberg EM, Medhus S, Tanum L, Franck J.

BMC Psychiatry. 2012 Dec 5;12:221. doi: 10.1186/1471-244X-12-221. Review.

13.

Trichotillomania, bipolar disorder and white matter hyperintensities in a six-year old girl.

Olza-Fernández I, Palanca-Maresca I, Jiménez-Fernández S, Cazorla-Calleja MR.

J Can Acad Child Adolesc Psychiatry. 2012 Aug;21(3):213-5.

14.

Unusual effects of nicotine as a psychostimulant on ambulatory activity in mice.

Umezu T.

ISRN Pharmacol. 2012;2012:170981. doi: 10.5402/2012/170981. Epub 2012 Mar 20.

15.

Methylphenidate-induced mania-like symptoms.

Chakraborty K, Grover S.

Indian J Pharmacol. 2011 Feb;43(1):80-1. doi: 10.4103/0253-7613.75678.

16.

The dopamine dilemma: using stimulants and antipsychotics concurrently.

Yanofski J.

Psychiatry (Edgmont). 2010 Jun;7(6):18-23.

17.
18.

The MTA at 8 years: prospective follow-up of children treated for combined-type ADHD in a multisite study.

Molina BS, Hinshaw SP, Swanson JM, Arnold LE, Vitiello B, Jensen PS, Epstein JN, Hoza B, Hechtman L, Abikoff HB, Elliott GR, Greenhill LL, Newcorn JH, Wells KC, Wigal T, Gibbons RD, Hur K, Houck PR; MTA Cooperative Group.

J Am Acad Child Adolesc Psychiatry. 2009 May;48(5):484-500. doi: 10.1097/CHI.0b013e31819c23d0.

19.

The efficacy and tolerability of methylphenidate and behavior modification in children with attention-deficit/hyperactivity disorder and severe mood dysregulation.

Waxmonsky J, Pelham WE, Gnagy E, Cummings MR, O'Connor B, Majumdar A, Verley J, Hoffman MT, Massetti GA, Burrows-MacLean L, Fabiano GA, Waschbusch DA, Chacko A, Arnold FW, Walker KS, Garefino AC, Robb JA.

J Child Adolesc Psychopharmacol. 2008 Dec;18(6):573-88. doi: 10.1089/cap.2008.065.

20.

Potential adverse effects of amphetamine treatment on brain and behavior: a review.

Berman SM, Kuczenski R, McCracken JT, London ED.

Mol Psychiatry. 2009 Feb;14(2):123-42. doi: 10.1038/mp.2008.90. Epub 2008 Aug 12. Review. Erratum in: Mol Psychiatry. 2010 Nov;15(11):1121.

Supplemental Content

Support Center